Application of QSAR and Shape Pharmacophore Modeling Approaches for Targeted Chemical Library Design

Methods in Molecular Biology

Volumn 685, Issue , 2011, Pages 111-133

  Ebalunode, Jerry O ^a   Zheng, Weifan ^a   Tropsha, Alexander ^b  

^a University of North Carolina Hospitals   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

model validation; pharmacophore modeling; QSAR modeling; virtual screening

Indexed keywords

CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER INTERFACE; DRUG SCREENING; METHODOLOGY; MOLECULAR LIBRARY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW;

DRUG EVALUATION, PRECLINICAL; MODELS, MOLECULAR; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SMALL MOLECULE LIBRARIES; USER-COMPUTER INTERFACE;

MLCS; MLOWN;

EID: 79952196849     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60761-931-4_6     Document Type: Chapter

References (88)

1. Zheng, W., Cho, S. J., Tropsha, A. (1998) Rational combinatorial library design. 1. Focus-2D: a new approach to the design of targeted combinatorial chemical libraries. J Chem Inf Comput Sci 38, 251–258.
2. ′98, Hawaii, Jan 4–9, 1998. World Scientific, Singapore, pp. 305–316.
3. Jamois, E. A. (2003) Reagent-based and product-based computational approaches in library design. Curr Opin Chem Biol 7, 326–330.
4. Irwin, J. J., Shoichet, B. K. (2005) ZINC–a free database of commercially available compounds for virtual screening. J Chem Inf Model 45, 177–182.
5. Oprea, T., Tropsha, A. (2006) Target, chemical and bioactivity databases – integration is key. Drug Discov Today 3, 357–365.
6. Varnek, A., Tropsha, A. (2008) Cheminformatics Approaches to Virtual Screening, RSC, London.
7. Tropsha, A. (2006) I in (Martin, Y. C., ed.) Comprehensive Medicinal Chemistry I. pp. 113–126, Elsevier, Oxford.
8. 2 ! J Mol Graph Model 20, 269–276.
9. Novellino, E., Fattorusso, C., Greco, G. (1995) Use of comparative molecular field analysis and cluster analysis in series design. Pharm Acta Helv 70, 149–154.
10. Norinder, U. (1996) Single and domain made variable selection in 3D QSAR applications. J Chemomet 10, 95–105.
11. Tropsha, A., Cho, S. J. (1998) in (Kubinyi, H., Folkers, G., and Martin, Y. C., eds.) 3D QSAR in Drug Design. Kluwer, Dordrecht, The Netherlands, pp. 57–69.
12. Tropsha, A., Gramatica, P., Gombar, V. K. (2003) The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models. Quant Struct Act Relat Comb Sci 22, 69–77.
13. Golbraikh, A., Tropsha, A. (2002) Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection. J Comput Aided Mol Des 16, 357–369.
14. Golbraikh, A., Shen, M., Xiao, Z., Xiao, Y. D., Lee, K. H., Tropsha, A. (2003) Rational selection of training and test sets for the development of validated QSAR models. J Comput Aided Mol Des 17, 241–253.
15. Pavan, M., Netzeva, T. I., Worth, A. P. (2006) Validation of a QSAR model for acute toxicity. SAR QSAR Environ Res 17, 147–171.
16. Vracko, M., Bandelj, V., Barbieri, P., Ben-fenati, E., Chaudhry, Q., Cronin, M., Devillers, J., Gallegos, A., Gini, G., Gramatica, P., Helma, C., Mazzatorta, P., Neagu, D., Netzeva, T., Pavan, M., Patlewicz, G., Randic, M., Tsakovska, I., Worth, A. (2006) Validation of counter propagation neural network models for predictive toxicology according to the OECD principles: a case study. SAR QSAR Environ Res 17, 265–284.
17. Saliner, A. G., Netzeva, T. I., Worth, A. P. (2006) Prediction of estrogenicity: validation of a classification model. SAR QSAR Environ Res 17, 195–223.
18. Roberts, D. W., Aptula, A. O., Patlewicz, G. (2006) Mechanistic applicability domains for non-animal based prediction of toxicological endpoints. QSAR analysis of the Schiff base applicability domain for skin sensitization. Chem Res Toxicol 19, 1228–1233.
19. Zhang, S., Golbraikh, A., Tropsha, A. (2006) Development of quantitative structure-binding affinity relationship models based on novel geometrical chemical descriptors of the protein-ligand interfaces. J Med Chem 49, 2713–2724.
20. Golbraikh, A., Bonchev, D., Tropsha, A. (2001) Novel chirality descriptors derived from molecular topology. J Chem Inf Comput Sci 41, 147–158.
21. Kovatcheva, A., Buchbauer, G., Golbraikh, A., Wolschann, P. (2003) QSAR modeling of alpha-campholenic derivatives with sandalwood odor. J Chem Inf Comput Sci 43, 259–266.
22. Kovatcheva, A., Golbraikh, A., Oloff, S., Xiao, Y. D., Zheng, W., Wolschann, P., Buchbauer, G., Tropsha, A. (2004) Combinatorial QSAR of ambergris fragrance compounds. J Chem Inf Comput Sci 44, 582–595.
23. Shen, M., Xiao, Y., Golbraikh, A., Gombar, V. K., Tropsha, A. (2003) Development and validation of k-nearest-neighbor QSPR models of metabolic stability of drug candidates. J Med Chem 46, 3013–3020.
24. Shen, M., LeTiran, A., Xiao, Y., Golbraikh, A., Kohn, H., Tropsha, A. (2002) Quantitative structure-activity relationship analysis of functionalized amino acid anticonvulsant agents using k nearest neighbor and simulated annealing PLS methods. J Med Chem 45, 2811–2823.
25. Shen, M., Beguin, C., Golbraikh, A., Stables, J. P., Kohn, H., Tropsha, A. (2004) Application of predictive QSAR models to database mining: identification and experimental validation of novel anticonvulsant compounds. J Med Chem 47, 2356–2364.
26. Zhang, S., Golbraikh, A., Oloff, S., Kohn, H., Tropsha, A. (2006) A Novel Automated Lazy Learning QSAR (ALL-QSAR) approach: method development, applications, and virtual screening of chemical databases using validated ALL-QSAR models. J Chem Inf Model 46, 1984–1995.
27. Golbraikh, A., Shen, M., Xiao, Z., Xiao, Y. D., Lee, K. H., Tropsha, A. (2003) Rational selection of training and test sets for the development of validated QSAR models. J Comput Aided Mol Des 17, 241–253.
28. Eriksson, L., Jaworska, J., Worth, A. P., Cronin, M. T., McDowell, R. M., Gramatica, P. (2003) Methods for reliability and uncertainty assessment and for applicability evaluations of classification-and regression-based QSARs. Environ Health Perspect 111, 1361–1375.
29. Sachs, L. (1984) Handbook of Statistics. Springer, Heidelberg.
30. Tropsha, A., Golbraikh, A. (2007) Predictive QSAR modeling workflow, model applicability domains, and virtual screening. Curr Pharm Des 13, 3494–3504.
31. Tropsha, A. (2005) in (Oprea, T., ed.) Cheminformatics in Drug Discovery., Wiley-VCH, New York, pp. 437–455.
32. Medina-Franco, J. L., Golbraikh, A., Oloff, S., Castillo, R., Tropsha, A. (2005) Quantitative structure-activity relationship analysis of pyridinone HIV-1 reverse transcriptase inhibitors using the k nearest neighbor method and QSAR-based database mining. J Comput Aided Mol Des 19, 229–242.
33. Oloff, S., Mailman, R. B., Tropsha, A. (2005) Application of validated QSAR models of D1 dopaminergic antagonists for database mining. J Med Chem 48, 7322–7332.
34. Zhang, S., Wei, L., Bastow, K., Zheng, W., Brossi, A., Lee, K. H., Tropsha, A. (2007) Antitumor Agents 252. Application of validated QSAR models to database mining: discovery of novel tylophorine derivatives as potential anticancer agents. J Comput Aided Mol Des 21, 97–112.
35. Hsieh, J. H., Wang, X. S., Teotico, D., Golbraikh, A., Tropsha, A. (2008) Differentiation of AmpC beta-lactamase binders vs. decoys using classification kNN QSAR modeling and application of the QSAR classifier to virtual screening. J Comput Aided Mol Des 22, 593–609.
36. Tang, H., Wang, X. S., Huang, X. P., Roth, B. L., Butler, K. V., Kozikowski, A. P., Jung, M., Tropsha, A. (2009) Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validation. J Chem Inf Model 49, 461–476.
37. Peterson, Y. K., Wang, X. S., Casey, P. J., Tropsha, A. (2009) Discovery of geranylgeranyltransferase-I inhibitors with novel scaffolds by the means of quantitative structure-activity relationship modeling, virtual screening, and experimental validation. J Med Chem 52, 4210–4220.
38. CCG. Molecular Operation Environment. 2008.
39. Molconn Z. http://www.edusoft-lc.com/molconn/. 2010.
40. Zheng, W., Tropsha, A. (2000) Novel variable selection quantitative structure–property relationship approach based on the k-nearest-neighbor principle. J Chem Inf Comput Sci 40, 185–194.
41. Cho, S. J., Zheng, W., Tropsha, A. (1998) Rational combinatorial library design. 2. Rational design of targeted combinatorial peptide libraries using chemical similarity probe and the inverse QSAR approaches. J Chem Inf Comput Sci 38, 259–268.
42. Tropsha, A., Zheng, W. (2001) Identification of the descriptor pharmacophores using variable selection QSAR: applications to database mining. Curr Pharm Des 7, 599–612.
43. DesJarlais, R. L., Sheridan, R. P., Seibel, G. L., Dixon, J. S., Kuntz, I. D., Venkataraghavan, R. (1988) Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure. J Med Chem 31, 722–729.
44. Grant, J. A., Gallardo, M. A., Pickup, B. T. (1996) A fast method of molecular shape comparison: a simple application of a Gaussian description of molecular shape. J Comput Chem 17, 1653–1666.
45. Zauhar, R. J., Moyna, G., Tian, L., Li, Z., Welsh, W. J. (2003) Shape signatures: a new approach to computer-aided ligand-and receptor-based drug design. J Med Chem 46, 5674–5690.
46. Meyer, A. Y., Richards, W. G. (1991) Similarity of molecular shape. J Comput Aided Mol Des 5, 427–439.
47. Good, A. C., Richards, W. G. (1993) Rapid evaluation of shape similarity using Gaussian functions. J Chem Inf Comput Sci 33, 112–116.
48. ROCS. version 3.0.0. 2009. Santa Fe, NM, USA, OpenEye Scientific Software.
49. OEShape Toolkit. version 1.7.2. 2009. Santa Fe, NM, USA, OpenEye Scientific Software.
50. Carbo, R., Domingo, L. (1987) Lcao-Mo similarity measures and taxonomy. Int J Quantum Chem 32, 517–545.
51. Carbo, R., Leyda, L., Arnau, M. (1980) An electron density measure of the similarity between two compounds. Int J Quantum Chem 17, 1185–1189.
52. Masek, B. B., Merchant, A., Matthew, J. B. (1993) Molecular shape comparison of angiotensin II receptor antagonists. J Med Chem 36, 1230–1238.
53. Ballester, P. J., Richards, W. G. (2007) Ultrafast shape recognition to search compound databases for similar molecular shapes. J Comput Chem 28, 1711–1723.
54. Breneman, C. M., Thompson, T. R., Rhem, M., Dung, M. (1995) Electron-density modeling of large systems using the transferable atom equivalent method. Comput Chem 19, 161.
55. Breneman, C. M., Sundling, C. M., Suku-mar, N., Shen, L., Katt, W. P., Embrechts, M. J. (2003) New developments in PEST shape/property hybrid descriptors. J Comput Aided Mol Des 17, 231–240.
56. Das, S., Kokardekar, A., Breneman, C. M. (2009) Rapid comparison of protein binding site surfaces with property encoded shape distributions. J Chem Inf Model 49, 2863–2872.
57. Nilakantan, R., Bauman, N., Venkataraghavan, R. (1993) New method for rapid characterization of molecular shapes: applications in drug design. J Chem Inf Comput Sci 33, 79–85.
58. Schlosser, J., Rarey, M. (2009) Beyond the virtual screening paradigm: structure-based searching for new lead compounds. J Chem Inf Model 49, 800–809.
59. Zauhar, R. J. (1995) SMART: a solvent-accessible triangulated surface generator for molecular graphics and boundary element applications. J Comput Aided Mol Des 9, 149–159.
60. Hawkins, P. C., Skillman, A. G., Nicholls, A. (2007) Comparison of shape-matching and docking as virtual screening tools. J Med Chem 50, 74–82.
61. McGaughey, G. B., Sheridan, R. P., Bayly, C. I., Culberson, J. C., Kreatsoulas, C., Lindsley, S., Maiorov, V., Truchon, J. F., Cornell, W. D. (2007) Comparison of topological, shape, and docking methods in virtual screening. J Chem Inf Model 47, 1504–1519.
62. Daylight. version 4.82. 2003. Aliso Viejo, CA, USA, Daylight Chemical Information Systems Inc.
63. Kearsley, S. K., Sallamack, S., Fluder, E. M., Andose, J. D., Mosley, R. T., Sheridan, R. P. (1996) Chemical similarity using physio-chemical property descriptors. J Chem Inf Comput Sci 36, 118–127.
64. Miller, M. D., Sheridan, R. P., Kearsley, S. K. (1999) SQ: a program for rapidly producing pharmacophorically relevant molecular superpositions. J Med Chem 42, 1505–1514.
65. Miller, M. D., Kearsley, S. K., Underwood, D. J., Sheridan, R. P. (1994) FLOG: a system to select ‘quasi-flexible’ ligands complementary to a receptor of known three-dimensional structure. J Comput Aided Mol Des 8, 153–174.
66. McGann, M. R., Almond, H. R., Nicholls, A., Grant, J. A., aBrown, F. K. (2003) Gaussian docking functions Biopolymers 68, 76–90.
67. Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., Shaw, D. E., Francis, P., Shenkin, P. S. (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47, 1739–1749.
68. Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., Banks, J. L. (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 47, 1750–1759.
69. Moffat, K., Gillet, V. J., Whittle, M., Bravi, G., Leach, A. R. (2008) A comparison of field-based similarity searching methods: Cat-Shape, FBSS, and ROCS. J Chem Inf Model 48, 719–729.
70. Hahn, M. (1997) Three-dimensional shape-based searching of conformationally flexible compounds. J Chem Inf Comput Sci 37, 80–86.
71. Wild, D. J., Willett, P. (1996) Similarity searching in files of three-dimensional chemical structures. Alignment of molecular electrostatic potential fields with a genetic algorithm. J Chem Inf Comput Sci 36, 159–167.
72. Ebalunode, J. O., Ouyang, Z., Liang, J., Zheng, W. (2008) Novel approach to structure-based pharmacophore search using computational geometry and shape matching techniques. J Chem Inf Model 48, 889–901.
73. Ebalunode, J. O., Zheng, W. (2009) Unconventional 2D shape similarity method affords comparable enrichment as a 3D shape method in virtual screening experiments. J Chem Inf Model 49, 1313–1320.
74. Nagarajan, K., Zauhar, R., Welsh, W. J. (2005) Enrichment of ligands for the sero-tonin receptor using the shape signatures approach. J Chem Inf Model 45, 49–57.
75. Ballester, P. J., Finn, P. W., Richards, W. G. (2009) Ultrafast shape recognition: evaluating a new ligand-based virtual screening technology. J Mol Graph Model 27, 836–845.
76. Tawa, G. J., Baber, J. C., Humblet, C. (2009) Computation of 3D queries for ROCS based virtual screens. J Comput Aided Mol Des 23, 853–868.
77. Kirchmair, J., Distinto, S., Markt, P., Schuster, D., Spitzer, G. M., Liedl, K. R., Wolber, G. (2009) How to optimize shape-based virtual screening: choosing the right query and including chemical information. J Chem Inf Model 49, 678–692.
78. Nagarajan, K., Zauhar, R., Welsh, W. J. (2005) Enrichment of ligands for the sero-tonin receptor using the shape signatures approach. J Chem Inf Model 45, 49–57.
79. Wolber, G., Langer, T. (2005) Ligand-Scout: 3-d pharmacophores derived from protein-bound Ligands and their use as virtual screening filters. J Chem Inf Model 45, 160–169.
80. Lee, H. S., Lee, C. S., Kim, J. S., Kim, D. H., Choe, H. (2009) Improving virtual screen- ing performance against conformational variations of receptors by shape matching with ligand binding pocket. J Chem Inf Model 49, 2419–2428.
81. Markt, P., Petersen, R. K., Flindt, E. N., Kristiansen, K., Kirchmair, J., Spitzer, G., Distinto, S., Schuster, D., Wolber, G., Lag-gner, C., Langer, T. (2008) Discovery of novel PPAR ligands by a virtual screening approach based on pharmacophore modeling, 3D Shape, and electrostatic similarity screening. J Med Chem 51, 6303–6317.
82. Rush, T. S., Grant, J. A., Mosyak, L., Nicholls, A. (2005) A shape-based 3-D scaffold hopping method and its application to a bacterial protein protein interaction. J Med Chem 48, 1489–1495.
83. Cramer, R. D., Poss, M. A., ermsmeier, M. A., Caulfield, T. J., Kowala, M. C., Valentine, M. T. (1999) Prospective identification of biologically active structures by topomer shape similarity searching. J Med Chem 42, 3919–3933.
84. Cramer, R. D., Jilek, R. J., Guessregen, S., Clark, S. J., Wendt, B., Clark, R. D. (2004) “Lead Hopping.” Validation of topomer similarity as a superior predictor of similar biological activities. J Med Chem 47, 6777–6791.
85. Muchmore, S. W., Souers, A. J., Akritopoulou-Zanze, I. (2006) The use of three-dimensional shape and electrostatic similarity searching in the identification of a melanin-concentrating hormone receptor 1 antagonist. Chem Biol Drug Des 67, 174–176.
86. Perez-Nueno, V. I., Ritchie, D. W., Rabal, O., Pascual, R., Borrell, J. I., Teixido, J. (2008) Comparison of ligand-based and receptor-based virtual screening of HIV entry inhibitors for the CXCR4 and CCR5 receptors using 3D ligand shape matching and ligand-receptor docking. J Chem Inf Model 48, 509–533.
87. Ballester, P. J., Westwood, I., Laurieri, N., Sim, E., Richards, W. G. (2010) Prospective virtual screening with Ultrafast shape recognition: the identification of novel inhibitors of arylamine N-acetyltransferases. J R Soc Interface 7, 335–342.
88. Ebalunode, J. O., Dong, X., Ouyang, Z., Liang, J., Eckenhoff, R. G., Zheng, W. (2009) Structure-based shape pharmacophore modeling for the discovery of novel anesthetic compounds. Bioorg Med Chem 17, 5133–5138.